Monday, February 11, 2019 6:37:55 AM
By Rick Archer
Law360 (February 6, 2019, 10:10 PM EST) -- Specialty drugmaker Avadel Specialty Pharmaceuticals filed for Chapter 11 in Delaware bankruptcy court Wednesday, saying slow sales growth for its nighttime urination drug caused its parent company to cut off funding after investing $152 million with minimal returns.
In the company's Chapter 11 declaration, Avadel said its corporate parent and sole funding source, Avadel Group member Avadel U.S. Holdings Inc., has invested $152 million since September in their attempt to launch Noctiva, its sole commercial product, but that the drug so far has less than $3 million in net sales.
"In light of the Avadel Group's broader restructuring, and as a result of its own ongoing financial and capital constraints, AUSH determined that it could no longer continue to fund ASP," Avadel president Gregory Divis said in the declaration.
The declaration said the company is part of the Dublin, Ireland-based Avadel Group, which is itself undergoing out-of-court restructuring.
The company has no other secured or unsecured debt, except for about $1.7 million in unsecured claims from vendors and other third parties, the declaration said.
The declaration said the company's sole commercial product is Noctiva, a nasal spray that treats nocturnal polyuria, a condition that causes the body to make too much urine at night.
The drug was approved by the U.S. Food and Drug Administration in March 2017, but there has been "minimal market demand" for the drug, with physicians unwilling to prescribe it, the declaration said. Managed care companies have also placed restrictions on the drug, resulting in more than half of all prescriptions so far being dispensed for free, it said.
"Making matters worse, sales projections based on the current growth trend illustrate a substantially longer period of operating losses than originally assumed," Divis said.
The declaration said the company will pursue an asset sale followed by a wind-down and liquidation of any unsold operations and assets.
Representatives of Avadel did not immediately respond to requests for comment late Wednesday.
Avadel is represented by Dennis A. Meloro, Paul J. Keenan Jr., John R. Dodd and Sara A. Hoffman of Greenberg Traurig LLP.
The case is In re: Avadel Specialty Pharmaceuticals LLC, case number 19-10248, in the U.S. Bankruptcy Court for the District of Delaware.
Recent AVDL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 09:18:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 10:01:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 11:00:35 AM
- Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII) • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Avadel Pharmaceuticals to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 11:00:38 AM
- Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension • GlobeNewswire Inc. • 08/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 01:25:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:12:15 AM
- Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:38:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:37:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:36:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:35:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:32:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:31:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:13:52 PM
- Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8 • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:48:55 PM
- Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia • GlobeNewswire Inc. • 07/31/2024 08:05:00 PM
- Avadel Pharmaceuticals to Join Russell 3000® Index • GlobeNewswire Inc. • 06/27/2024 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 06/18/2024 11:25:39 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/18/2024 11:17:01 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/18/2024 11:11:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM